This drug is used in the treatment of mild to moderate community-acquired pneumonia. Acute bacterial exacerbation of chronic bronchitis caused by Haemophilus influenza, pneumonia due to various susceptible strains.

A mild to moderate range of side effects has been observed. Side effects such as nausea, vomiting, fever, headache, rash, muscle weakness, dizziness, and tachycardia occur in some cases.

This drug is to be prescribed cautiously in patients with muscle disorders or any nervous system-related disorders. In patients with long QT syndrome, and patients with hepatic disorders.

This drug is contraindicated in patients with hypersensitivity to the fluoroquinolone class of drugs.

The usual single dose for adults is 320 mg administered orally post meals 24 hours a day.

We have established our roots in other countries as well, such as Belgium, France metropolitan, the USSR, and Saint Helena.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai